CIK: 0001839948 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $1,264,902 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY, INC. | 3,570,206 | $156,732 | 12.4% | $40.84 | 0.0% | COMM | 156944100 |
| DYN | DYNE THERAPEUTICS, INC | 2,650,150 | $75,238 | 5.9% | $16.62 | +36.1% | COMM | 26818M108 |
| — | ASTRIA THERAPEUTICS, INC. | 5,278,928 | $74,301 | 5.9% | $14.07 | — | COMM | 04635X102 |
| SLN | SILENCE THERAPEUTICS PLC | 3,295,350 | $71,180 | 5.6% | $14.21 | — | ADRS | 82686Q101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,598,421 | $68,508 | 5.4% | $43.22 | — | ADRS | 86366E106 |
| — | AEROVATE THERAPEUTICS INC | 2,201,274 | $65,092 | 5.1% | $15.75 | — | COMM | 008064107 |
| — | INHIBRX,INC | 1,750,387 | $61,194 | 4.8% | $18.35 | — | COMM | 45720L107 |
| KROS | KEROS THERAPEUTICS, INC. | 879,344 | $58,213 | 4.6% | $59.30 | 0.0% | COMM | 492327101 |
| GERN | GERON CORP | 17,391,639 | $57,392 | 4.5% | $1.89 | +18.4% | COMM | 374163103 |
| SVRA | SAVARA INC. | 10,000,000 | $49,800 | 3.9% | $3.56 | +35.5% | COMM | 805111101 |
| OCUL | OCULAR THERAPEUTIX, INC. | 5,319,148 | $48,404 | 3.8% | $7.10 | 0.0% | COMM | 67576A100 |
| COGT | COGENT BIOSCIENCES INC | 6,214,375 | $41,761 | 3.3% | $9.23 | -33.0% | COMM | 19240Q201 |
| EWTX | EDGEWISE THERAPEUTICS, INC. | 2,272,728 | $41,455 | 3.3% | $15.89 | 0.0% | COMM | 28036F105 |
| MLYS | MINERALYS THERAPEUTICS, INC. | 3,185,185 | $41,121 | 3.3% | $12.35 | 0.0% | COMM | 603170101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 149,283 | $39,865 | 3.2% | $110.42 | +113.4% | COMM | 558868105 |
| — | TOURMALINE BIO INC | 1,477,593 | $33,837 | 2.7% | $25.14 | — | COMM | 89157D105 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $32,621 | 2.6% | $12.71 | +29.1% | COMM | 90240B106 |
| CMPS | COMPASS PATHWAYS PLC | 3,858,000 | $32,099 | 2.5% | $7.40 | — | ADRS | 20451W101 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $30,366 | 2.4% | $14.54 | +33.7% | COMM | 50127T109 |
| TARS | TARSUS PHARMACEUTICALS, INC. | 793,829 | $28,856 | 2.3% | $17.70 | +66.2% | COMM | 87650L103 |
| — | ADVERUM BIOTECHNOLOGIES, INC. | 2,008,340 | $28,398 | 2.2% | $14.14 | — | COMM | 00773U108 |
| — | SOLENO THERAPEUTIVS, INC. | 550,000 | $23,540 | 1.9% | $42.80 | — | COMM | 834203200 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,040,816 | $23,061 | 1.8% | $6.47 | — | COMM | 152309100 |
| ABVX | Abivax SA | 1,100,000 | $15,730 | 1.2% | $10.70 | — | ADRS | 00370M103 |
| — | VISTAGEN THERAPEUTICS INC | 2,676,580 | $14,132 | 1.1% | $5.14 | — | COMM | 92840H202 |
| KALV | KALVISTA PHARMACEUTICALS, INC | 1,163,356 | $13,797 | 1.1% | $5.36 | +148.9% | COMM | 483497103 |
| CCCC | C4 THERAPEUTICS, INC. | 1,276,574 | $10,430 | 0.8% | $5.83 | +32.9% | COMM | 12529R107 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $8,289 | 0.7% | $17.12 | — | COMM | 29384C108 |
| ANTX | AN2 Therapeutics, Inc. | 1,555,118 | $5,054 | 0.4% | $9.33 | +16.6% | COMM | 037326105 |
| KOD | KODIAK SCIENCES INC | 899,999 | $4,734 | 0.4% | $4.10 | +19.4% | COMM | 50015M109 |
| VTYX | VENTYX BIOSCIENCES, INC | 815,724 | $4,486 | 0.4% | $29.94 | -84.7% | COMM | 92332V107 |
| — | NEKTAR THERAPEUTICS | 4,000,000 | $3,737 | 0.3% | $0.93 | — | COMM | 640268108 |
| CABA | CABALETTA BIO, INC | 86,795 | $1,481 | 0.1% | $3.64 | +489.5% | COMM | 12674W109 |